Decreased plasma membrane expression of striatal dopamine transporter in aging

Aging in rodents, monkeys, and man is correlated with a reduction in dopamine transporter (DAT) ligand binding and DAT function. Using Western blot techniques, we investigated whether the source of these age-related changes in DAT was correlated with decreases in DAT protein levels in the striatum, substantia nigra (SN), nucleus accumbens (NAc), and ventral tegmental area (VTA) of 6, 18, and 24-month-old male Fischer 344 rats. The relative levels of tyrosine hydroxylase (TH) were also determined in each region. In the striatum, we also assessed [3H]-DA uptake and DAT plasma membrane expression using a membrane-impermeant biotin analog in crude synaptosomes prepared from these age groups. There was no significant age-related difference in DAT immunoreactivity per total protein or per total TH in striatum, NAc, SN, or VTA. Significant age-related changes in TH were only seen in the VTA of the 24-month-old rats (approximately 60% decrease). However, [3H]-DA uptake and DAT protein recovered in the biotinylated fraction in 24-month-old rats were significantly decreased (approximately 30%) compared to 6-month-old animals in the striatal synaptosomes. These data suggest that age-related decreases in striatal DAT function and ligand binding are related to a decrease in plasma membrane expression of DAT and not a decrease in the steady-state levels of DAT protein or loss of dopaminergic neuropil.

[1]  E. Krebs,et al.  Association of mitogen-activated protein kinase with the microtubule cytoskeleton. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Yu Wang,et al.  Protein kinase‐mediated bidirectional trafficking and functional regulation of the human dopamine transporter , 1998, Synapse.

[3]  R. Blakely,et al.  Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. , 1996, Molecular pharmacology.

[4]  G. Gerhardt,et al.  Changes in somatodendritic but not terminal dopamine
regulation in aged rhesus monkeys , 2002, Journal of neurochemistry.

[5]  Patrick R. Hof,et al.  Functional neurobiology of aging , 2001 .

[6]  Greg A. Gerhardt,et al.  Age-related changes in potassium-evoked overflow of dopamine in the striatum of the rhesus monkey , 1995, Neurobiology of Aging.

[7]  G. Gerhardt,et al.  Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in Fischer 344 rats , 1998, Brain Research.

[8]  Michael J. Bannon,et al.  Age‐related and regional differences in dopamine transporter mRNA expression in human midbrain , 1997, Neurology.

[9]  J. Haycock,et al.  Striatal 3,4‐dihydroxyphenylalanine decarboxylase in aging: Disparity between postmortem and positron emission tomography studies? , 1995, Annals of neurology.

[10]  G. Gerhardt,et al.  Differences in pharmacological properties of dopamine release between the substantia nigra and striatum: an in vivo electrochemical study. , 1999, The Journal of pharmacology and experimental therapeutics.

[11]  N. Zahniser,et al.  Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. , 2001, Pharmacology & therapeutics.

[12]  N. Morel,et al.  VAMP (synaptobrevin) is present in the plasma membrane of nerve terminals. , 1999, Journal of cell science.

[13]  M. Rice,et al.  Novel Ca2+ Dependence and Time Course of Somatodendritic Dopamine Release: Substantia Nigra versus Striatum , 2001, The Journal of Neuroscience.

[14]  J. Haycock Quantitation of tyrosine hydroxylase, protein levels: spot immunolabeling with an affinity-purified antibody. , 1989, Analytical biochemistry.

[15]  J. Holden,et al.  Age‐related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys , 1998, The Journal of comparative neurology.

[16]  G. Gerhardt,et al.  Age-related reductions in [3H]WIN 35,428 binding to the dopamine transporter in nigrostriatal and mesolimbic brain regions of the fischer 344 rat. , 1999, The Journal of pharmacology and experimental therapeutics.

[17]  D. Mash,et al.  Dopamine transporter‐immunoreactive neurons decrease with age in the human substantia nigra , 1999, The Journal of comparative neurology.

[18]  H. Melikian,et al.  Membrane Trafficking Regulates the Activity of the Human Dopamine Transporter , 1999, The Journal of Neuroscience.

[19]  N. Zahniser,et al.  Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes. , 2001, The Journal of pharmacology and experimental therapeutics.

[20]  L A Beckett,et al.  Prevalence of parkinsonian signs and associated mortality in a community population of older people. , 1996, The New England journal of medicine.

[21]  S J Kish,et al.  Biochemical pathophysiology of Parkinson's disease. , 1987, Advances in neurology.

[22]  Janet R. Saffer,et al.  Effects of age on dopamine transporters in healthy humans. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  S. Amara,et al.  Regulated Trafficking of the Human Dopamine Transporter , 1999, The Journal of Biological Chemistry.

[24]  M. Kuhar,et al.  The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  N. Volkow,et al.  Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging , 1998, Annals of neurology.

[26]  G. Uhl,et al.  Protein Kinase C-mediated Phosphorylation and Functional Regulation of Dopamine Transporters in Striatal Synaptosomes* , 1997, The Journal of Biological Chemistry.

[27]  A. Deutch,et al.  Stoichiometry of Tyrosine Hydroxylase Phosphorylation in the Nigrostriatal and Mesolimbic Systems In Vivo , 2000, Journal of neurochemistry.

[28]  G. Gerhardt,et al.  Biochemical and Anatomical Changes in Basal Ganglia of Aging Animals , 2001 .

[29]  N. Zahniser,et al.  Brief, repeated exposure to substrates down‐regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo , 2002, Journal of neurochemistry.

[30]  R. Blakely,et al.  Biogenic amine transporters: regulation in flux , 2000, Current Opinion in Neurobiology.

[31]  R. Blakely,et al.  Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins. , 1998, The Journal of pharmacology and experimental therapeutics.

[32]  G. Gerhardt,et al.  Age-related changes in the capacity, rate, and modulation of dopamine uptake within the striatum and nucleus accumbens of Fischer 344 rats: an in vivo electrochemical study. , 1999, The Journal of pharmacology and experimental therapeutics.

[33]  M. Wolf,et al.  Effect of Aging on Tyrosine Hydroxylase Protein Content and the Relative Number of Dopamine Nerve Terminals in Human Caudate , 1991, Journal of neurochemistry.

[34]  M. Bannon,et al.  Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Marc G Caron,et al.  Monoamine transporters: from genes to behavior. , 2003, Annual review of pharmacology and toxicology.

[36]  Y. Agid,et al.  Preservation of midbrain catecholaminergic neurons in very old human subjects. , 2000, Brain : a journal of neurology.

[37]  K. Vrana,et al.  Regulation of Rat Dopamine Transporter mRNA and Protein by Chronic Cocaine Administration , 1999, Journal of neurochemistry.

[38]  J. Marcusson,et al.  Age-correlated loss of dopamine uptake sites labeled with [3H]GBR-12935 in human putamen , 1989, Neurobiology of Aging.

[39]  J. Scheys,et al.  Cocaine induction of dopamine transporter trafficking to the plasma membrane. , 2002, Molecular pharmacology.

[40]  G. Gerhardt,et al.  Regional effects of aging on dopaminergic function in the Fischer-344 rat , 1992, Neurobiology of Aging.

[41]  G. Gerhardt,et al.  Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats , 1999, Brain Research.